Switzerland's Tillotts Pharma AG launches ulcerative colitis drug in China

Tillotts Pharma AG (“Tillotts”), part of the Japanese Zeria Group, announced that the recent launch of Asaco...

July 29, 2021 | Thursday | News
Longer-interval of Pfizer vaccine dose boosts antibody levels: Study

Universities of Sheffield, Oxford, Liverpool, Newcastle, and Birmingham, with support from the UK Coronavirus Immunology...

July 23, 2021 | Friday | News
Clarivate introduces a revolutionary digital pharma supply chain network

Clarivate Plc has launched Cortellis Supply Chain Network™, a part of the Cortellis suite of life scienc...

July 23, 2021 | Friday | News
Russia enacts law to enable Real-World Evidence research for pharma companies

Under the law, Data MATRIX will be able to conduct retrospective clinical studies without signing informed con...

July 22, 2021 | Thursday | News
UK designs strategy to be the global hub for R&D and innovation by 2035

The UK government has set out plans to make the UK the best destination in the world for researchers, making sure that i...

July 22, 2021 | Thursday | News
Novigenix wins 2021 Felix Burda award in Medicine & Science

Novigenix SA, a leading Swiss biotech that develops and commercializes Immuno-Transcriptomic precision oncology solution...

July 22, 2021 | Thursday | News
Menarini Asia-Pacific strengthens men's health portfolio in China

Menarini Asia-Pacific Holdings Pte. Ltd., part of the Menarini Group, the world's largest Italian biopharmaceutical comp...

July 22, 2021 | Thursday | News
Vetter’s new clinical manufacturing site now fully integrated

Expansion of clinical capacity to address growing market demand Site status now ‘ready for media fill’ N...

July 21, 2021 | Wednesday | News
Cognizant enhances smart manufacturing capabilities backed by data intelligence

Cognizant is set to acquire TQS Integration, a privately owned global industrial data and intelligence company based in ...

July 21, 2021 | Wednesday | News
New research demonstrates faster COVID-19 recovery with metabolic activator treatment

Metabolic activators were found to reduce recovery time by as many as 3.5 days in patients with mild-to-moderate Covid-1...

July 21, 2021 | Wednesday | News
Terumo Europe and UMCU ink MoU to develop solutions in interventional oncology

Terumo Europe and University Medical Center Utrecht (UMC Utrecht) have announced that they signed a Memorandum of Unders...

July 21, 2021 | Wednesday | News
Frontier Biotechnologies launches two drug regimen for HIV

In conjunction with the IAS Conference on HIV Science, Germany's Frontier Biotechnologies has announced positive top-lin...

July 19, 2021 | Monday | News
The UK government launches 'UK Life Sciences Vision'

The United Kingdom (UK) government aims to accelerate the delivery of novel innovations at patient care through the ...

July 19, 2021 | Monday | News
NEC's AI tool aids in determining whether colorectal lesions are potentially neoplastic

Japan's NEC Corporation announced the development of an AI technology for supporting doctors in determining if colorecta...

July 15, 2021 | Thursday | News
Anticancer Bioscience appoints Dr. Hong Liu, as US-based VP of clinical development

Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced the appointment of...

July 14, 2021 | Wednesday | News
PAI Health partners with Zurich Brazil to improve health outcomes

British Columbia-based PAI Health launched a 12-month pilot program with Zurich Brazil, a regional subsidiary ...

July 13, 2021 | Tuesday | News
Servier and Nymirum collaborate to develop RNA-Targeted small molecule therapeutics

Paris-based Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, ...

July 13, 2021 | Tuesday | News
QuantuMDx launches Q-POC rapid PCR point of care diagnostic system in the UK

QuantuMDx Group Limited, a UK-based developer of transformational point-of-care diagnostics, announces the launch of Q-P...

July 9, 2021 | Friday | News